Platinum Gr Metals (AMEX:PLG) Stock, Quote.Headers.trade-ideas

Platinum Gr Metals

Platinum Group Metals Ltd is the operator of the Waterberg Project, a bulk underground PGM deposit located in South Africa. Waterberg was discovered by Platinum Group and is being jointly developed with Implats, the Japan Oil, Gas and Metals National Corporation (JOGMEC) and Hanwa Co. Ltd. Waterberg has the potential to be a large-scale, low-cost producer of palladium, platinum, rhodium, and gold. Geographically, it operates in Canada and South Africa.

News

Penny Stocks

Small Cap

Pre-Market Outlook

Markets

Movers

Trading Ideas

ACON

APCX

APSG

ATTO

AVYA

BBAI

BGXX

BTTX

CANG

CLEU

CMRX

CRCT

CRGE

CRMT

CTEK

CUTR

DADA

DPSI

ESEA

EXPR

FEMY

GFAI

GMBL

GNCA

IMBI

INMB

KALA

LQDA

LYFT

MSPR

NEON

NXPL

OKYO

OSCR

OSUR

PINS

PRCH

PRPL

PUBM

QUBT

REAL

ROKU

SFIX

SNAP

SOBR

SOTK

SPRC

TCBP

TELA

TXMD

VEDU

VGFC

WKME

XFOR

ZTEK

Gainers


	CynergisTek, Inc.  (NYSE: CTEK) shares surged 100% to close at $1.18 on Tuesday after the company entered into a definitive agreement to be acquired by Clearwater Compliance for roughly $17.7 million.


71 Biggest Movers From Yesterday

Specialty ETFs

Commodities

Events

Global

ETFs

AMRK

ETFS Physical Precious Metal Basket Shares

GLTR

PALL

SBSW

SPPP

PLPT

Russia&#39;s invasion of Ukraine and resulting sanctions on Russia are putting pressure on several sectors including commodities. Two precious metals that could be affected by the global crisis are palladium and platinum.

Why Traders Need To Watch Palladium And Platinum Stocks Right Now

AEZS

AMTD

BBWI

EBAY

ENSV

EZGO

FIVN

HUSA

IMPP

INDO

LMND

MAPS

MILE

NRGV

NTAP

ORPH

OZON

Qualigen Therapeutics, Inc. - Common Stock

QLGN

RCII

Renovare Environmental, Inc. - Common Stock

RENO

REVB

SKLZ

SNMP

TRMR

USWS

YNDX

Gainers


	Imperial Petroleum Inc. (NASDAQ: IMPP) rose 45.1% to $1.64 in pre-market trading after gaining around 41% on Wednesday.


32 Stocks Moving in Thursday&#39;s Pre-Market Session

Platinum Group Metals Ltd. Ordinary Shares (Canada)

Platinum Group Metals Ltd

PLAYLOGIC ENTMT INC by Playlogic Entertainment, Inc.

Playlogic Entertainment Inc

PALISADES GOLDCORP LTD by PALISADES GOLDCORP LTD.

Palisades Goldcorp Ltd

ENERGY PLUG TECH CORP by ENERGY PLUG TECHNOLOGIES CORP.

Energy Plug Technologies Corp

Playgon Games Inc

Options

PCRX

PETS

PLBY

PSNY

PSNYW

PULM

QRTEA

RANI

REBN

RENT

RVLV

RVNC

RVTY

SAFT

SCLX

SCNI

SEDG

SKIN

SLDB

SLGG

SNPX

SOHU

SPCE

SQFT

STKL

Sunlight Financial Holdings, Inc. Class A Common Stock

SUNL

SUNW

SVVC

SXTP

TARA

THCH

TMCI

Tempest Therapeutics, Inc. - Common Stock

TPST

TRVN

TTEC

UFCS

ULCC

VERO

VNCE

VRAX

VRNT

VSAT

WISA

WKHS

WOOF

XNCR

Stocks That Hit 52-Week Lows On Friday

Results For The Six Month Period Ended February 28, 2023
During the six month period ended February 28, 2023, the Company incurred a net loss of&nbsp;$2.81 million&nbsp;(February 28, 2022 -&nbsp;$5.95 million). Cash based expenses for the six month period were&nbsp;54%&nbsp;lower than for the same period in fiscal 2022.
General and administrative expenses during the current period were lower at&nbsp;$2.03 million&nbsp;(February 28, 2022 -&nbsp;$2.44 million), with the higher expense for the six month period ended February 28, 2022 being primarily due to legal expenses for our successful defense at trial against claims by Africa Wide, which took place during October 2021 and February 2022. Interest expense was $Nil in the current period versus&nbsp;$1.65 million&nbsp;in the comparable six month period of fiscal 2022. The Company repaid all its remaining debt in February 2022, thereby eliminating related future interest expense. The foreign exchange gain recognized in the current period was&nbsp;$0.30 million&nbsp;(February 28, 2022 -&nbsp;$0.06 million&nbsp;loss) due to the U.S. Dollar increasing in value relative to the Canadian Dollar during the current period. Joint venture expenses related to battery research and development work by Lion were&nbsp;$0.29 million&nbsp;during the six month period (February 28, 2022 -&nbsp;$0.25 million). Stock compensation was&nbsp;$1.11 million&nbsp;during the period (February 28, 2022 -&nbsp;$1.28 million).
At February 28, 2023, finance income consisting of interest earned and property rental fees in the period amounted to&nbsp;$0.32 million&nbsp;(February 28, 2022 -&nbsp;$0.05 million).
Loss per share for the current period amounted to&nbsp;$0.03, as compared to a loss of&nbsp;$0.07&nbsp;per share for the six-month period ended February 28, 2022.
Amounts receivable at February 28, 2023, totalled&nbsp;$0.45 million&nbsp;(August 31, 2022 -&nbsp;$0.38 million) while accounts payable and accrued liabilities amounted to&nbsp;$0.90 million&nbsp;(August 31, 2022 -&nbsp;$1.12 million). Amounts receivable were comprised mainly of value added taxes repayable to the Company in South Africa. Accounts payable consisted primarily of Waterberg engineering fees, infill and geotechnical drilling costs, accrued professional fees and regular trade payables.
Total expenditures on the Waterberg Project, before partner reimbursements, for the six month period ended February 28, 2023 were approximately&nbsp;$2.0 million&nbsp;(February 28, 2022 -&nbsp;$1.9 million). After accounting for foreign exchange gains or losses related to the U.S. Dollar, at February 28, 2023,&nbsp;$39.9 million&nbsp;in accumulated net costs were capitalized to the Waterberg Project (February 28, 2022 -&nbsp;$43.2 million). Total expenditures on the property since inception from all investor sources to February 28, 2023 are approximately&nbsp;$82.9 million. For more information about the Waterberg Project, see Note 3. of the Financial Statements, &quot;Mineral Properties and Exploration and Evaluation Assets&quot;.
Outlook
The Company&#39;s primary business objective is to advance the Waterberg Project to a development and construction decision. PTM is the operator of the Waterberg Project as directed by a technical committee comprised of representatives from joint venture partners Impala Platinum Holdings Ltd. (&quot;Implats&quot;), Mnombo Wethu Consultants (Pty) Ltd. (&quot;Mnombo&quot;), Japan Organization for Metals and Energy Security (formerly Japan Oil, Gas and Metals National Corporation) (&quot;JOGMEC&quot;) and Hanwa Co., Ltd. (&quot;Hanwa&quot;). Before project financing and a construction decision can be undertaken, arrangements will be required for project concentrate offtake or processing.
On October 18, 2022, Waterberg JV Co. approved in principle the pre-construction Work Program (as described above) of approximately&nbsp;$21.0 million&nbsp;over a 23-month period ending August 31, 2024. The Work Program is focussed on project infrastructure including initial road access, water supply, essential site facilities, a first phase accommodation lodge, a site construction power supply from state utility Eskom and advancement of the Waterberg Social &amp; Labour Plan. An update to the 2019 Waterberg Definitive Feasibility Study (&quot;DFS Update&quot;) is also planned, including a review of cut-off grades, mining methods, infrastructure plans, scheduling, concentrate offtake, dry stack tailings, costing and other potential revisions to the project&#39;s financial model.
From the Work Program, an Initial Budget of approximately&nbsp;$2.5 million&nbsp;was approved for expenditure by March 31, 2023. The Initial Budget included thirty-two infill boreholes and several geotechnical holes. The Stage Two Budget for&nbsp;$3.6 million&nbsp;in work was approved for expenditure on March 24, 2023. The Stage Two Budget includes DFS Update engineering, pre-construction engineering, electrical power supply engineering and the permitting and licensing of construction aggregate borrow pits identified near the Waterberg mine site.
The Initial Budget and the Stage Two Budget are being funded pro rata by the joint venture partners. Subsequent expenditures in accordance with the Work Program are subject to expected approvals for the next sequential time period beginning September 1, 2023.
The Company continues to work closely with regional and local communities and their leadership on mine development plans to achieve optimal outcomes and best value to all stakeholders.
The Company is considering commercial alternatives for mine development, financing and concentrate offtake. Obtaining reasonable terms for Waterberg concentrate offtake from an existing smelter/refiner in South Africa is considered the preferred option and discussions with such parties are ongoing. As an alternative to a traditional concentrate offtake arrangement, the Company is assessing the economic feasibility of constructing a matte furnace and base metal refinery, either with or without partners, to process Waterberg concentrate. The NI 43-101 definitive feasibility study technical report for the Waterberg Project entitled &quot;Independent Technical Report, Waterberg Project Definitive Feasibility Study and Mineral Resource Update, Bushveld Complex, South Africa&quot; dated October 4, 2019, stated that &quot;Additional smelting capacity may need to be constructed in the industry to be able to treat the flotation concentrate from Waterberg and the other potential Platreef miners&quot;. A matte furnace and base metal refinery as described above is envisioned as a separate business from Waterberg JV Co. that could provide fair market concentrate offtake terms to Waterberg JV Co. and possibly to other PGM miners. Discussions with potential participating partners and investors are ongoing.
As the world seeks to decarbonize and look for solutions to climate change, the adoption of battery electric vehicles is forecast to reduce the future demand for PGMs used in autocatalysis. The unique properties of PGMs as powerful catalysts are being applied to various technologies as possible solutions for more efficient energy generation and storage, which may create new demand for PGMs. The Company&#39;s battery technology initiative through Lion with partner Anglo represents one such new opportunity in the high-profile lithium battery research and innovation field. The investment in Lion creates a potential vertical integration with a broader industrial market development strategy to bring new technologies to market which use palladium and platinum. Research and development efforts by FIU on behalf of Lion continue. Technical results from Lion&#39;s research may have application to most lithium-ion battery chemistries and the scope of Lion&#39;s research work is being expanded.

Earnings

Reported Late Wednesday April 12, Platinum Group Metals Ltd. Reports Q2 Results; 1H 2022 EPS $(0.03) Vs $(0.07) YoY

Platinum Group Metals FY22 EPS $(0.09) Up From $(0.18) For FY21

Offerings

Platinum Group Metals Files For Mixed-Securities Shelf Offering Of Up To $250M

<h3>Gainers</h3>
<ul>
<li>CynergisTek, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ctek#NYSE">CTEK</a>) shares surged 100% to close at $1.18 on Tuesday after the company entered into a definitive agreement to be acquired by Clearwater Compliance for roughly $17.7 million.</li>
<li>Better Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bttx#NASDAQ">BTTX</a>) jumped 69.8% to settle at $2.19 after dropping 12% on Monday. Better Therapeutics recently posted a Q1 loss of $0.41 per share.</li>
<li>America&#39;s Car-Mart, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crmt#NASDAQ">CRMT</a>) shares surged 30.8% to close at $99.98 after reporting better-than-expected Q4 results.</li>
<li>Quantum Computing, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qubt#NASDAQ">QUBT</a>) gained 26.3% to close at $1.97. Quantum Computing&rsquo;s 8-K showed that the company and Project Alpha Merger entered deal to buy QPhoton.</li>
<li>Platinum Group Metals Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/plg#NYSE">PLG</a>) jumped 23.5% to settle at $1.68.</li>
<li>SciSparc Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sprc#NASDAQ">SPRC</a>) rose 22.8% to close at $2.80. SciSparc disclosed positive safety profile results from its joint pre-clinical trial with Clearmind Medicine Inc. for its psychedelic combination treatment.</li>
<li>AppTech Payments Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apcx#NASDAQ">APCX</a>) gained 20.4% to close at $0.9033.</li>
<li>China Liberal Education Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cleu#NASDAQ">CLEU</a>) shares jumped 17.9% to close at $2.50.</li>
<li>Zentek Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ztek#NASDAQ">ZTEK</a>) jumped 17.8% to close at $1.79.</li>
<li>Guardforce AI Co., Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gfai#NASDAQ">GFAI</a>) shares gained 16.2% to close at $0.7251 after jumping around 14% on Monday.</li>
<li>Charge Enterprises, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crge#NASDAQ">CRGE</a>) surged 13.3% to close at $3.66. Maxim Group initiated coverage on Charge Enterprises with a Buy rating and announced a price target of $8.</li>
<li>NextPlat Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxpl#NASDAQ">NXPL</a>) jumped 12.3% to settle at $2.1899. NextPlat recently reported a first-quarter net sales increase of 144% year-over-year to $3.58 million.</li>
<li>Sono-Tek Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sotk#NASDAQ">SOTK</a>) rose 11.1% to close at $6.69. Sono-Tek posted FY22 sales of $17.1 million.</li>
<li>Euroseas Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/esea#NASDAQ">ESEA</a>) climbed 8.2% to settle at $30.20 after the company reported better-than-expected Q1 EPS and sales results and announced a stock buyback up to $20 million.</li>
<li>Neonode Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/neon#NASDAQ">NEON</a>) jumped 7.3% to close at $6.00. Neonode recently posted a Q1 loss of $0.10 per share.</li>
<li>Decisionpoint Systems, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dpsi#NYSE">DPSI</a>) shares gained 6.4% to close at $5.86. DecisionPoint Systems recently reported first-quarter FY22 revenue growth of 22.7% year-on-year to $19.7 million.</li>
</ul>
&nbsp;
&nbsp;
<h3>Losers</h3>
<ul>
<li>Genocea Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gnca#NASDAQ">GNCA</a>) shares dipped 72.7% to close at $0.0609 on Tuesday after the company announced it is winding down operations and delisting from NASDAQ.</li>
<li>MSP Recovery Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mspr#NASDAQ">MSPR</a>) shares fell 53.1% to close at $5.06. MSP Recovery&rsquo;s Class A Common Stock and warrants started trading today.</li>
<li>Snap Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/snap#NYSE">SNAP</a>) dipped 43.1% to close at $12.79. The parent company of Snapchat filed a form 8-K with the U.S. Securities and Exchange Commission to lower its previously-issued guidance for the second quarter. When Snap originally issued its guidance for the quarter on April 21, the company forecast second-quarter revenues to come in 20% to 25% above the same period the year prior.</li>
<li>BigBear.ai Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bbai#NYSE">BBAI</a>) fell 39.6% to close at $6.11. BigBear.ai Holdings recently posted a Q1 loss of $0.14 per share.</li>
<li>WalkMe Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wkme#NASDAQ">WKME</a>) declined 34.4% to close at $8.00 following Q1 results.</li>
<li>TC Biopharm (Holdings) Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcbp#NASDAQ">TCBP</a>) dropped 34.2% to settle at $0.7770. TC BioPharm recently reported formation of scientific advisory board with renowned cell therapy experts.</li>
<li>Abercrombie &amp; Fitch Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/anf#NYSE">ANF</a>) shares fell 28.6% to settle at $19.09 after the company reported Q1 earnings results and issued guidance.</li>
<li>Liquidia Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lqda#NASDAQ">LQDA</a>) dropped 28.3% to settle at $3.37. Liquidia Technologies recently posted a Q1 loss of $0.30 per share.</li>
<li>Atento S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/atto#NYSE">ATTO</a>) declined 28.2% to close at $9.58. Atento recently reported Q1 results.</li>
<li>Standard BioTools Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lab#NASDAQ">LAB</a>) fell 25% to close at $1.95.</li>
<li>INmune Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inmb#NASDAQ">INMB</a>) dropped 24.6% to settle at $5.48 after the company reported the FDA requested additional information around Chemistry Manufacturing and Controls of XPro1595 and placed the IND application to initiate its Phase 2 clinical trial on clinical hold.</li>
<li>Pinterest, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pins#NYSE">PINS</a>) dipped 23.6% to close at $17.25 after Snap filed a Form 8-K with the U.S. Securities and Exchange Commission showing the company expects to miss its previously-issued guidance.</li>
<li>Chimerix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmrx#NASDAQ">CMRX</a>) dropped 23% to close at $1.81.</li>
<li>Apollo Strategic Growth Capital (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/apsg#NYSE">APSG</a>) fell 22.4% to close at $7.61.</li>
<li>Avaya Holdings Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/avya#NYSE">AVYA</a>) dipped 21.7% to close at $3.22.</li>
<li>Kala Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kala#NASDAQ">KALA</a>) tumbled 21.6% to close at $0.4751 as HC Wainwright &amp; Co. maintained Buy on the stock and lowered price target to $4. Kala Pharmaceuticals said it would sell its EYSUVIS and INVELTYS treatments for $60 million.</li>
<li>Aclarion, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acon#NASDAQ">ACON</a>) dropped 21.1% to close at $1.38.</li>
<li>Cricut, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crct#NASDAQ">CRCT</a>) fell 20.2% to close at $6.71. Cricut recently reported worse-than-expected Q1 sales results.</li>
<li>Agora, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/api#NASDAQ">API</a>) dropped 19.7% to close at $5.38 following weak quarterly earnings.</li>
<li>Cutera, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cutr#NASDAQ">CUTR</a>) declined 19.4% to close at $41.31. Cutera recently posted a Q1 loss of $0.84 per share.</li>
<li>Express, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/expr#NYSE">EXPR</a>) fell 19.3% to settle at $2.38. Express is expected to release quarterly results on May 25, 2022.</li>
<li>Nautilus, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nls#NYSE">NLS</a>) fell 19.1% to close at $2.03 after the company reported worse-than-expected Q4 sales results and issued FY23 sales guidance below analyst estimates.</li>
<li>TELA Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tela#NASDAQ">TELA</a>) dipped 19.1% to settle at $6.71. TELA Bio recently posted a Q1 loss of $0.75 per share.</li>
<li>OraSure Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/osur#NASDAQ">OSUR</a>) dropped 19% to settle at $4.51. Carrie Eglinton Manner has been appointed Chief Executive Officer of OraSure.</li>
<li>The Trade Desk, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ttd#NASDAQ">TTD</a>) fell 18.5% to close at $42.78.</li>
<li>Youdao, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dao#NYSE">DAO</a>) dropped 18.1% to close at $4.52 following Q1 results.</li>
<li>Esports Entertainment Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gmbl#NASDAQ">GMBL</a>) declined 18% to close at $0.3586. Esports Entertainment Group reported third-quarter FY22 sales growth of 190.8% year-on-year, to $15.7 million, missing the consensus of $16.86 million.</li>
<li>Cango Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cang#NYSE">CANG</a>) fell 17.9% to close at $2.99 after gaining around 10% on Monday.</li>
<li>Porch Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prch#NASDAQ">PRCH</a>) declined 17.9% to close at $3.85. JP Morgan recently initiated coverage on the stock with an Overweight rating and announced an $8 price target.</li>
<li>The Very Good Food Company Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vgfc#NASDAQ">VGFC</a>) fell 17.8% to settle at $0.1352.</li>
<li>Femasys Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/femy#NASDAQ">FEMY</a>) declined 17.6% to close at $1.45. Femasys recently posted a Q1 loss of $0.24 per share.</li>
<li>Lyft, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lyft#NASDAQ">LYFT</a>) dipped 17.3% to close at $16.72. Bernstein assumed Lyft with a Market Perform rating and lowered the price target to $22.</li>
<li>The RealReal, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/real#NASDAQ">REAL</a>) fell 16.6% to settle at $2.66.</li>
<li>Oscar Health, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/oscr#NYSE">OSCR</a>) dipped 16.6% to settle at $4.74. Oscar Health recently posted a Q1 loss of $0.36 per share.</li>
<li>Sprout Social, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spt#NASDAQ">SPT</a>) dipped 16.2% to close at $40.02.</li>
<li>OKYO Pharma Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/okyo#NASDAQ">OKYO</a>) fell 16.2% to settle at $2.22.</li>
<li>iMedia Brands, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/imbi#NASDAQ">IMBI</a>) dipped 16.1% to close at $1.72. iMedia Brands reported first-quarter FY22 sales growth of 37% year-on-year to $154.5 million.</li>
<li>TherapeuticsMD, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/txmd#NASDAQ">TXMD</a>) fell 16% to close at $2.15. TherapeuticsMD recently announced that it has received FDA approval of its supplemental New Drug Application for ANNOVERA.</li>
<li>Skyline Champion Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sky#NYSE">SKY</a>) dropped 15.9% to settle at $45.10. Skyline Champion recently reported better-than-expected Q4 EPS and sales results.</li>
<li>PubMatic, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pubm#NASDAQ">PUBM</a>) dipped 15.8% to settle at $18.37. PubMatic recently reported better-than-expected Q1 adjusted EPS and sales results.</li>
<li>Aurora Innovation, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aur#NASDAQ">AUR</a>) dipped 15.7% to settle at $2.95.</li>
<li>Rite Aid Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rad#NYSE">RAD</a>) fell 15.7% to close at $4.77.</li>
<li>Visionary Education Technology Holdings Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vedu#NASDAQ">VEDU</a>) declined 15.6% to settle at $1.57.</li>
<li>Stitch Fix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sfix#NASDAQ">SFIX</a>) fell 15.6% to close at $7.08.</li>
<li>SOBR Safe, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sobr#NASDAQ">SOBR</a>) dipped 15.4% to close at $1.10.</li>
<li>GDS Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gds#NASDAQ">GDS</a>) fell 14.1% to close at $25.01. GDS Holdings recently posted a Q1 net loss of $58.9 million.</li>
<li>Roku, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/roku#NASDAQ">ROKU</a>) fell 13.7% to close at $79.16.</li>
<li>Purple Innovation, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prpl#NASDAQ">PRPL</a>) declined 13.4% to close at $4.71.</li>
<li>Fisker Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fsr#NYSE">FSR</a>) dropped 12.8% to close at $9.61. Fisker announced the launch of its $350 million at the market offering program.</li>
<li>Dada Nexus Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dada#NASDAQ">DADA</a>) fell 12.5% to close at $5.73.</li>
<li>Global Internet of People, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sdh#NASDAQ">SDH</a>) fell 12.1% to settle at $1.46.</li>
<li>Studio City International Holdings Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/msc#NYSE">MSC</a>) dropped 11.6% to close at $2.05.</li>
<li>Bright Green Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bgxx#NASDAQ">BGXX</a>) fell 11.4% to close at $11.77 after jumping 18% on Monday.</li>
<li>Full Truck Alliance Co. Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ymm#NYSE">YMM</a>) fell 11% to close at $4.94.</li>
<li>X4 Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xfor#NASDAQ">XFOR</a>) shares fell 6.8% to close at $1.23 after gaining 12% on Monday.</li>
</ul>

Russia&#39;s invasion of Ukraine and resulting sanctions on Russia are putting pressure on several sectors including commodities. Two precious metals that could be affected by the global crisis are palladium and platinum.
What Happened: The U.S. and other countries are <a href="https://www.benzinga.com/government/22/02/25764301/biden-unveils-first-wave-of-sanctions-against-russia-promising-we-have-our-next-move-prepared">imposing sanctions</a> on Russia, which could impact exports out of the country across varying sectors.
Russia is the largest global producer of <a href="https://www.benzinga.com/money/best-palladium-stocks/">palladium </a>and the No. 2 producer of platinum, two metals that could be impacted by the Eastern European conflict.&nbsp;
Thirty-nine percent of the global refined supply of palladium comes from Russia, according to <a href="https://www.kitco.com/news/2022-02-22/Watch-palladium-gold-and-silver-prices-as-West-sanctions-Russia-in-response-to-Ukraine-crisis.html">Kitco</a>. The country also accounts for around 11% of global platinum supply.
Palladium is used by automotive manufacturers,&nbsp;in electronics and in jewelry. Platinum is the third most-traded precious metal in the world behind gold and silver and is also used for automotive and&nbsp;jewelry applications along with&nbsp;industrial and medical items.
Palladium was up nearly 7% to $2,648&nbsp;per ounce on Thursday. The metal started the year trading around $1,905 and is now up over 30% year-to-date.
Platinum was down more than 1% at $1,094&nbsp;and is up around 15% year-to-date.
Right now, exporters of metals in Russia have not been affected by sanctions, but that could change and the tensions could continue to increase the price of the metals.
The rising price and potential supply issues could hurt the already ailing automotive sector, which&nbsp;has seen supply issues with chips. Companies like General Motors Corp (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gm#NYSE">GM</a>) and Ford Motor Co (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/f#NYSE">F</a>) are&nbsp;companies that could see price increases or supply constraints.
Palladium <a href="https://www.etftrends.com/palladium-etf-could-rally-in-2022/">hit </a>an all-time high of $3,017 an ounce in May 2021 before falling on production cuts from the auto industry.
Stocks: Many of the precious metals stocks trade over the counter&nbsp;or on international exchanges. The following are a few&nbsp;stocks on major exchanges that offer exposure to palladium and/or platinum.
Platinum Group Metals (AMEX: PLG) is the <a href="https://platinumgroupmetals.net/">operator </a>of the Waterberg Project, which has deposits of metals like palladium and platinum. The company has seen shares rise over the last two trading sessions with shares up 3.97% to $2.10 on Thursday.&nbsp;
Sibanye Stillwater (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sbsw#NYSE">SBSW</a>) is a <a href="https://www.sibanyestillwater.com/">miner </a>of several minerals and among the largest producers of platinum and palladium in the world. The company reported 144,325 ounces of PGM (platinum group metals-platinum, palladium, rhodium, iridium, osmium and ruthenium) <a href="https://thevault.exchange/?get_group_doc=245/1635420558-ssw-Q32021-operating-update-28Oct2021.pdf">produced </a>in the third quarter in its U.S. division and 500,073 ounces in its South African division. Shares of SBSW were up 2.7% to $17.87&nbsp;on Thursday.&nbsp;
A-Mark Precious Metals Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amrk#NASDAQ">AMRK</a>) is a precious metals company with operations across gold, silver, copper, platinum, palladium and other metals. A-Mark offers wholesale sales, secured lending and direct-to-consumer operations.
Related Link: <a href="https://www.benzinga.com/government/22/02/25757480/15-stocks-to-watch-during-russia-ukraine-conflict">15 Stocks To watch During Russia, Ukraine Conflict&nbsp;</a>
ETFs: Several mining and metals ETFs&nbsp;offer exposure to palladium and platinum. Here are some investment options for those seeking exposure to the metals.
Aberdeen Standard Physical Palladium Shares ETF&nbsp;(ARCA: PALL) has over $400 million in assets under management and is one of the largest holders of physical palladium. Shares of PALL were up 4.78% on Thursday, closing at $243.53.
Aberdeen also offers a pure-play platinum ETF with the Aberdeen Standard Physical Platinum Shares ETF (ARCA: PLPT). The ETF was launched in 2010 and has over $1.2 billion of assets under management.
The Sprott Physical Platinum &amp; Palladium Trust (ARCA: SPPP) <a href="https://www.sprott.com/investment-strategies/physical-bullion-trusts/platinum-and-palladium/#">invests </a>in physical palladium and platinum and offers exposure to both metals. The ETF was launched in 2012 and gives investors options to redeem their ETF units for physical metals if requirements are met.
The Aberdeen Standard Physical Precious Metals Basket Shares ETF (ARCA: GLTR) is less of a pure-play on the two mentioned metals with exposure to gold, silver, palladium and platinum. The ETF could offer exposure to the two metals most affected by raising political tensions along with two metals that are considered hedges against inflation and market uncertainty.

<h3>Gainers</h3>
<ul>
<li>Imperial Petroleum Inc.&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/impp#NASDAQ">IMPP</a>) rose 45.1% to $1.64 in pre-market trading after gaining around 41% on Wednesday.</li>
<li>Camber Energy, Inc.&nbsp; (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cei#NYSE">CEI</a>) rose 40.5% to $0.8345 in pre-market trading after jumping more than 30% on Wednesday.</li>
<li>Enservco Corporation&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ensv#NYSE">ENSV</a>) rose 38.9% to $1.16 in pre-market trading after gaining around 43% on Wednesday.</li>
<li>Indonesia Energy Corporation Limited&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/indo#NYSE">INDO</a>) rose 33.7% to $10.07 in pre-market trading following a 16% surge on Wednesday.</li>
<li>U.S. Well Services, Inc.&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/usws#NASDAQ">USWS</a>) shares rose 25.6% to $1.19 in pre-market trading. US Well Services recently reported finalization of electric frac contract with Olympus Energy.</li>
<li>Evolve Transition Infrastructure LP&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/snmp#NYSE">SNMP</a>) shares rose 23.1% to $0.5050 in pre-market trading after climbing 19% on Wednesday.</li>
<li>PEDEVCO Corp.&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ped#NYSE">PED</a>) rose 12.9% to $1.49 in pre-market trading.</li>
<li>Tremor International Ltd&nbsp; (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/trmr#NYSE">TRMR</a>) rose 12.7% to $14.37 in pre-market trading. Tremor International recently said it has increased TV data reach to 44 million US households.</li>
<li>Houston American Energy Corp.&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/husa#NYSE">HUSA</a>) rose 11% to $1.61 in pre-market trading after jumping 14% on Wednesday.</li>
<li>Platinum Group Metals Ltd. &nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/plg#NYSE">PLG</a>) rose 9.9% to $2.22 in pre-market trading after gaining 9% on Wednesday.</li>
<li>WM Technology, Inc.&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/maps#NASDAQ">MAPS</a>) rose 9.3% to $4.80 in pre-market trading after the company reported better-than-expected Q4 sales results and issued FY22 sales guidance above estimates.</li>
</ul>
&nbsp;
Find out what&#39;s going on in today&#39;s market and bring any questions you have to <a href="http://premarket.benzinga.com/pre-market-show/">Benzinga&#39;s PreMarket Prep</a>.
<a href="https://www.benzinga.com/news/22/02/25774625/tesla-and-4-other-stocks-sold-by-insiders">Check out this: Tesla And 4 Other Stocks Sold By Insiders</a>
<h3>Losers</h3>
<ul>
<li>Rent-A-Center, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rcii#NASDAQ">RCII</a>) shares fell 38.6% to $21.33 in pre-market trading after the company reported worse-than-expected Q4 results and issued weak guidance.</li>
<li>Skillz Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sklz#NYSE">SKLZ</a>) fell 35.2% to $2.34 in pre-market trading after the company reported worse-than-expected Q4 sales results and issued FY22 sales guidance below estimates.</li>
<li>Orphazyme A/S (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/orph#NASDAQ">ORPH</a>) shares fell 28.7% to $1.44 in pre-market trading after the company issued an update on regulatory review of arimoclomol in the European Union.</li>
<li>Aeterna Zentaris Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aezs#NASDAQ">AEZS</a>) fell 26.8% to $0.2526 in pre-market trading.</li>
<li>Qualigen Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qlgn#NASDAQ">QLGN</a>) shares fell 24.3% to $0.50 in pre-market trading after dropping over 4% on Wednesday.</li>
<li>Yandex N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/yndx#NASDAQ">YNDX</a>) fell 23.7% to $25.95 in pre-market trading after dipping 14% on Wednesday.</li>
<li>Ozon Holdings PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ozon#NASDAQ">OZON</a>) shares fell 23.1% to $11.72 in pre-market trading after dipping 13% on Wednesday.</li>
<li>Lemonade, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lmnd#NYSE">LMND</a>) shares fell 20.8% to $18.15 in pre-market trading after the company issued Q1 and FY22 sales guidance below estimates.</li>
<li>Metromile, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mile#NASDAQ">MILE</a>) shares fell 20.5% to $0.93 in pre-market trading after declining 8% on Wednesday.</li>
<li>Mechel PAO (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mtl#NYSE">MTL</a>) fell 20% to $2.32 in pre-market trading after declining 6% on Wednesday.</li>
<li>AMTD International Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amtd#NYSE">AMTD</a>) fell 19.8% to $5.50 in pre-market trading. AMTD International shares jumped 78% on Wednesday following the company&#39;s completion of its purchase of a majority stake in AMTD Digital.</li>
<li>Revelation Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/revb#NASDAQ">REVB</a>) shares fell 18.3% to $1.70 in pre-market trading after jumping 35% on Wednesday.</li>
<li>Renovare Environmental, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/reno#NASDAQ">RENO</a>) fell 18.2% to $0.3599 in pre-market trading.</li>
<li>EZGO Technologies Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ezgo#NASDAQ">EZGO</a>) fell 17.7% to $0.7488 in pre-market trading following a 4% decline on Wednesday.</li>
<li>Ultrapar Participa&ccedil;&otilde;es S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ugp#NYSE">UGP</a>) fell 17.7% to $2.48 in pre-market trading.</li>
<li>Energy Vault Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nrgv#NYSE">NRGV</a>) shares fell 16.9% to $10.14 in pre-market trading after gaining around 9% on Wednesday.</li>
<li>TD Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/glg#NASDAQ">GLG</a>) shares fell 17.2% to $0.1723 in pre-market trading.</li>
<li>Five9, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fivn#NASDAQ">FIVN</a>) fell 15.6% to $87.80 in pre-market trading after the company issued Q1 adjusted EPS guidance below estimates.</li>
<li>eBay Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ebay#NASDAQ">EBAY</a>) shares fell 10% to $49.15 in pre-market trading after the company issued Q1 and FY22 EPS and sales guidance below estimates.</li>
<li>NetApp, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ntap#NASDAQ">NTAP</a>) fell 9% to $76.50 in pre-market trading after the company issued Q4 adjusted EPS guidance below estimates.</li>
<li>Bath &amp; Body Works, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bbwi#NYSE">BBWI</a>) fell 6.3% to $47.13 in pre-market trading after the company reported Q4 earnings results and issued guidance.</li>
</ul>
&nbsp;
Also check this out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/22/02/25773377/insiders-buying-incyte-and-2-more-stocks">Insiders Buying Incyte And 2 More Stocks</a>.

32 Stocks Moving in Thursday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Zogenix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zgnx#NASDAQ">ZGNX</a>) shares surged 65.7% to close at $25.92 on Wednesday after the company announced it will be acquired by UCB for approximately $1.9 billion.</li>
<li>G Medical Innovations Holdings Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gmvd#NASDAQ">GMVD</a>) jumped 45.4% to close at $6.12. EH Hutton, on Tuesday, initiated coverage on the stock with a Buy rating and a $6 price target.</li>
<li>Valneva SE (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/valn#NASDAQ">VALN</a>) gained 45% to close at $47.52 after results from an initial laboratory study demonstrated that serum antibodies induced by three doses of Valneva&#39;s COVID-19 vaccine candidate, VLA2001, neutralize the omicron variant.</li>
<li>Vivos Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vvos#NASDAQ">VVOS</a>) surged 41.1% to settle at $2.30 after the company announced significant increases across several key metrics for its SleepImage Home Sleep Apnea Tests.</li>
<li>ShiftPixy, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pixy#NASDAQ">PIXY</a>) gained 31.5% to close at $1.67.</li>
<li>NSTS Bancorp, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nsts#NASDAQ">NSTS</a>) jumped 25.9% to close at $12.59 after the company priced its IPO at $10 per share.</li>
<li>Evofem Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/evfm#NASDAQ">EVFM</a>) gained 22.9% to close at $0.4875. Evofem Biosciences achieved preliminary net product sales of $3.5 million in Q4 FY21, more than double in Q3 FY21.</li>
<li>Gamida Cell Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gmda#NASDAQ">GMDA</a>) shares rose 22.5% to close at $2.72. Gamida Cell announced that following receipt of positive Type B meeting correspondence from the FDA. The company said it plans to initiate a rolling biologics license application submission for omidubicel, a potentially life-saving treatment for patients with blood cancers in need of stem cell transplant.</li>
<li>ReTo Eco-Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/reto#NASDAQ">RETO</a>) gained 22% to settle at $2.16.</li>
<li>Splash Beverage Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sbev#NASDAQ">SBEV</a>) rose 21.9% to settle at $3.96 after the company announced it has received authorization to sell its Pulpoloco Sangria line in 187 of Ralph&#39;s Grocery stores.</li>
<li>Muscle Maker, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gril#NASDAQ">GRIL</a>) gained 21.6% to close at $0.6290 after the company signed two additional franchise agreements in the Mississippi market.</li>
<li>Platinum Group Metals Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/plg#NYSE">PLG</a>) surged 20.7% to settle at $1.98.</li>
<li>Aura Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aura#NASDAQ">AURA</a>) 19.9% to settle at $19.50.</li>
<li>Fresh Vine Wine, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vine#NYSE">VINE</a>) gained 19.6% to close at $6.70 after jumping around 9% on Tuesday. Fresh Vine Wine recently announced a partnership with CRAVE American Kitchen &amp; Sushi Bar.</li>
<li>Fusion Pharmaceuticals Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fusn#NASDAQ">FUSN</a>) jumped 19.3% to close at $8.17. Fusion Pharmaceuticals recently announced a research collaboration with 48Hour Discovery to develop peptide-based radiopharmaceuticals.</li>
<li>New Pacific Metals Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/newp#NYSE">NEWP</a>) gained 17.7% to close at $3.20.</li>
<li>WiMi Hologram Cloud Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wimi#NASDAQ">WIMI</a>) rose 16.7% to settle at $3.00.</li>
<li>Harmony Gold Mining Company Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hmy#NYSE">HMY</a>) gained 16.3% to close at $4.20.</li>
<li>International Tower Hill Mines Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/thm#NYSE">THM</a>) gained 15.8% to close at $0.8525.</li>
<li>Renren Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/renn#NYSE">RENN</a>) jumped 15.3% to close at $21.04.</li>
<li>SoFi Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sofi#NASDAQ">SOFI</a>) rose 13.7% to settle at $13.71. The San Francisco-based digital financial services company said Tuesday it had gained approvals from key regulators to become a full-fledged bank.</li>
<li>Reading International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rdib#NASDAQ">RDIB</a>) gained 13.4% to close at $22.70.</li>
<li>Hecla Mining Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hl#NYSE">HL</a>) surged 11.8% to close at $5.78. HC Wainwright &amp; Co. recently maintained Hecla Mining with a Buy and lowered the price target from $7.5 to $7.25.</li>
<li>Endeavour Silver Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/exk#NYSE">EXK</a>) climbed 11.7% to settle at $4.67. Endeavour Silver recently announced plans to acquire The Pitarrilla Project for $70 million in cash and stock.</li>
<li>SilverCrest Metals Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/silv#NYSE">SILV</a>) gained 11.3% to close at $8.65.</li>
<li>Gatos Silver, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gato#NYSE">GATO</a>) gained 11.3% to close at $11.35. Gatos Silver recently said Q4 silver production up 35% from the previous quarter.</li>
<li>Kanzhun Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bz#NASDAQ">BZ</a>) rose 8.4% to close at $28.18.</li>
<li>Vaxxinity, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vaxx#NASDAQ">VAXX</a>) gained 7.9% to close at $7.94. Vaxxinity recently announced the first Parkinson&#39;s disease patient has been dosed in Part B of a Phase 1 clinical trial of UB-312.</li>
<li>Bird Global, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/brds#NYSE">BRDS</a>) shares rose 6.6% to close at $3.73.</li>
</ul>
&nbsp;
<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>
<h3>Losers</h3>
<ul>
<li>Cardiff Oncology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crdf#NASDAQ">CRDF</a>) shares fell 25.9% to close at $4.55 on Wednesday after the company posted new data from Phase 1b/2 trial of onvansertib combined with standard-of-care (SOC) FOLFIRI/bevacizumab for second-line KRAS-mutated metastatic colorectal cancer (mCRC).</li>
<li>OncoCyte Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocx#NASDAQ">OCX</a>) shares fell 24.2% to close at $2.0550. OncoCyte announced a development and co-marketing agreement for two distributed in vitro diagnostic assays on Thermo Fisher Scientific&rsquo;s Ion Torrent Genexus System.</li>
<li>Dingdong (Cayman) Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ddl#NYSE">DDL</a>) dipped 23.8% to settle at $6.10.</li>
<li>Petros Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ptpi#NASDAQ">PTPI</a>) dropped 21.1% to close at $1.83. Petros Pharmaceuticals recently launcheed 2 self-selection studies for erectile dysfunction drug STENDRA.</li>
<li>Orion Energy Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/oesx#NASDAQ">OESX</a>) dipped 17% to settle at $3.31 after the company lowered its FY22 sales forecast.</li>
<li>electroCore, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ecor#NASDAQ">ECOR</a>) fell 16.3% to close at $0.6901. ElectroCore filed for mixed shelf of up to $75 million.</li>
<li>Yumanity Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ymtx#NASDAQ">YMTX</a>) fell 16.1% to settle at $2.0550 after the company reported partial clinical hold by the US FDA on multidose clinical trials for YTX-7739.</li>
<li>Cerberus Cyber Sentinel Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ciso#NASDAQ">CISO</a>) shares dropped 16.1% to close at $4.22.</li>
<li>Kinnate Biopharma Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/knte#NASDAQ">KNTE</a>) fell 15.7% to close at $12.85. Kinnate Biopharma announced FDA clearance of investigational drug application for KIN-3248.</li>
<li>Clearfield, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clfd#NASDAQ">CLFD</a>) dropped 15.6% to close at $55.66.</li>
<li>NeuroMetrix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nuro#NASDAQ">NURO</a>) fell 14.4% to close at $5.45. NeuroMetrix, on Tuesday, announced its Quell technology received Breakthrough Designation from the FDA for reducing moderate to severe symptoms of chemotherapy induced peripheral neuropathy.</li>
<li>PolarityTE, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pte#NASDAQ">PTE</a>) dropped 14% to settle at $0.6174. PolarityTE recently announced the FDA has approved its investigational new drug application for the evaluation of SkinTE for the treatment of chronic cutaneous ulcers.</li>
<li>EQRx, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eqrx#NASDAQ">EQRX</a>) fell 13.5% to close at $5.43. EQRx, along with its partner CStone Pharmaceuticals has announced data from Phase 3 GEMSTONE-302 trial of sugemalimab plus chemotherapy as a first-line treatment for stage IV non-small cell lung cancer (NSCLC).</li>
<li>Cardiol Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crdl#NASDAQ">CRDL</a>) dipped 13.4% to close at $2.00.</li>
<li>Phunware, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/phun#NASDAQ">PHUN</a>) shares fell 12.9% to close at $2.83 after jumping over 12% on Tuesday.</li>
<li>Vinco Ventures, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bbig#NASDAQ">BBIG</a>) dropped 12.7% to close at $4.53 after jumping over 27% on Tuesday.</li>
<li>Trio-Tech International (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/trt#NYSE">TRT</a>) dipped 12.4% to close at $6.90.</li>
<li>Tritium DCFC Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dcfc#NASDAQ">DCFC</a>) dropped 11% to close at $8.01.</li>
<li>Ensysce Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ensc#NASDAQ">ENSC</a>) shares fell 10.4% to close at $3.10 after jumping more than 5% on Tuesday.</li>
<li>DatChat, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dats#NASDAQ">DATS</a>) fell 10.2% to close at $2.99. DatChat shares jumped over 38% on Tuesday after the company announced it has initiated the development of a new platform that will leverage DatChat technology to share and protect NFTs, documents, audio and video files and messages.</li>
<li>Venus Concept Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vero#NASDAQ">VERO</a>) fell 9.8% to settle at $1.56. Venus Concept announced it received 510(k) clearance from the FDA to market the Venus BlissMAX device in the United States.</li>
<li>Immuron Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/imrn#NASDAQ">IMRN</a>) fell 9.2% to settle at $3.84.</li>
<li>Brickell Biotech, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bbi#NASDAQ">BBI</a>) shares fell 7.3% to close at $0.3060. Brickell Biotech shares jumped over 58% on Tuesday after HC Wainwright &amp; Co initiated coverage on the stock with a Buy rating and $2 price target.</li>
</ul>

Comments

Platinum Gr Metals

Platinum Gr Metals (PLG) Forecast

Platinum Gr Metals (AMEX:PLG) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga